Journal Mobile Options
Table of Contents
Vol. 86, No. 3, 2004
Issue release date: October 2004
Biol Neonate 2004;86:212–216
(DOI:10.1159/000079619)

Diagnosis of Acute Renal Failure in Very Preterm Infants

Choker G. · Gouyon J.B.
Service de Pédiatrie 2, Dijon, France

Individual Users: Register with Karger Login Information

Please create your User ID & Password





Contact Information











I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Abstract

This study was designed to improve the definition of acute renal failure (ARF) in very preterm infants. Twenty-eight newborn infants with gestational age ≤32 weeks were prospectively studied in the first 5 days of life and made up a control group as they did not present risk factors for vasomotor renal insufficiency. Renal insufficiency was defined as an increase in daily serum creatinine concentration above the 99th interval limit obtained in this control group, i.e., 43 µmol/l on day 1 and/or 21 µmol/l on day 2 and/or 14 µmol/l/day on day 3 and/or 22 µmol/l/day on day 4. According to this definition, 20 very preterm infants with ARF were identified. As compared with the control group, the ARF group showed more prolonged oliguric episodes, lower diuresis, insufficient weight loss (in spite of a reduction in water intake) and also more episodes with natremia <130 mEq/l (35 vs. 0%; p < 0.05) and/or kalemia >6 mEq/l (40 vs. 11%; p < 0.05). Therefore, assessment of daily changes in serum creatinine concentration in very preterm infants allows the diagnosis of clinically significant reduction in glomerular filtration rate.



Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

References

  1. Stapleton F, Jones D, Green R: Acute renal failure in neonates: Incidence, etiology and outcome. Pediatr Nephrol 1987;1:314–320.
  2. Hentschel R, Lodige B, Bulla M: Renal insufficiency in the neonatal period. Clin Nephrol 1996;46:54–58.
  3. Gouyon JB, Guignard JP: Management of acute renal failure in newborns. Pediatr Nephrol 2000;14:1037–1044.
  4. Guignard JP, Drukker A: Why do newborn infants have a high plasma creatinine? Pediatrics 1999;103:E49.

    External Resources

  5. Gallini et all: Progression of renal function in preterm neonates with gestational age ≤32 weeks. Pediatr Nephrol 2000;15:119–124.
  6. Semama DS, Bouziane M, Allaert FA, Gouyon JB: Body fluid osmolality and tonicity in preterm infants. Pediatr Nephrol 2001;16:906–910.
  7. Gouyon JB, Bouziane M, Semama DS: Objectifs des apports hydrosodés dans la première semaine de vie du prématuré: Comment les atteindre? In Gouyon JB, Guignard JP, Siméoni U (eds): Néphrologie périnatale. Equilibre hydroélectrolytique du grand prématuré. Paris, Arnette, 1997, vol 1, pp 99–118.
  8. Lorenz JM, Kleinman LI, Kotagal UR, Reller MD: Water balance in very low-birth-weight infants: Relationship to water and sodium intake and effect on outcome. J Pediatr 1982;101:423–432.
  9. Gouyon JB, Sonveau N, d’Athis P, Chaillot B: Accuracy of urine output measurement with regular disposable nappies. Pediatr Nephrol 1994;8:88–90.
  10. Bouyer J: Méthodes statistiques: Médecine – Biologie. Paris, INSERM, 1997.
  11. Chevalier R, Campbell F, Brenbridge A: Prognostic factors in neonatal acute renal failure. Pediatrics 1984;74:265–272.
  12. Lorenz JM, Kleinman LI, Ahmed G, Markarian K: Phases of fluid and electrolyte homeostasis in the extremely low birth weight infant. Pediatrics 1995;96:484–489.
  13. Manzke H, Spreter von Kreudenstein P, Dörner K, Kruse K: Quantitative measurements of the urinary excretion of creatinine, uric acid, hypoxanthine and xanthine, uracil, cyclic AMP and cyclic CMP in healthy newborn infants. Eur J Pediatr 1980;133:157–161.
  14. Van den Anker JN, De Groot R, Broerse HM, Sauer PJJ: Assessment of glomerular filtration rate in preterm infants by serum creatinine: Comparison with inulin clearance. Pediatrics 1995;96:1156–1158.
  15. Bergman I, Hirsch RP, Fria TJ, Shapiro SM, Holzman I, Painter MJ: Cause of hearing loss in high-risk premature infant. J Pediatr 1985;106:95–101.
  16. Ertl T, Hadziev K, Vincze O, Pytel J, Szabo I, Sulyok E: Hyponatremia and sensorineural hearing loss in preterm infants. Biol Neonate 2001;79:109–112.
  17. Leslie GI, Kalaw MB, Bowen JR, Arnold JD: Risk factors for sensorineural hearing loss in extremely premature infants. J Paediatr Child Health 1995;31:312–316.
  18. Murphy DJ, Hope PL, Johnson A: Neonatal risk factors for cerebral palsy in very preterm babies: A case-control study. Br Med J 1997;314:404–408.
  19. Al-Dahhan J, Jannoun L, Haycock GB: Effect of salt supplementation of newborn premature infants neurodevelopmental outcome at 10–13 years of age. Arch Dis Child Fetal Neonatal Ed 2002;86:F120–123.

    External Resources

  20. Lien Y, Shapiro JL, Chan L: Study of brain electrolytes and organic osmolytes during correction of chronic hyponatremia. Implications for the pathogenesis of pontine myelinolysis. J Clin Invest 1991;88:303–309.
  21. Gouyon JB, Guignard JP: Drugs and renal insufficiency in the neonate. Biol Neonate 1986;50:177–181.
  22. Gruskay J, Costarino AT, Polin RA, Baumgart S: Non-oliguric hyperkalemia in the premature infant weighing less than 1,000 grams. J Pediatr 1988;113:381–386.
  23. Sato K, Kondo T, Iwao H, Honda S, Ueda K: Internal potassium shift in premature infants: Cause of non-oliguric hyperkalemia. J Pediatr 1995;126:109–113.
  24. Fukuda Y, Kojima T, Ono A, Matsuzaki S, Iwase S, Kobayashi Y: Factors causing hyperkalemia in premature infants. Am J Perinatol 1989;6:76–79.
  25. Lorenz JM, Kleinman LI, Markarian K: Potassium metabolism in extremely low birth weight infants in the first week of life. J Pediatr 1997;131:81–86.


Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50